Try our Advanced Search for more refined results
麻豆传媒 UK
-
March 11, 2025
Motorola, Ericsson License Terms Clarified Ahead Of Trial
A London court on Tuesday marked the boundaries of Motorola's 2011 license to use Ericsson's cellular technology, helping set the stage for the Swedish company's FRAND showdown with the Lenovo group later in the year.
-
March 11, 2025
Roche Gets Illumina Unit's DNA Testing Patent Revoked
Roche has persuaded a European appeals panel to revoke an Illumina Inc. subsidiary's patent over a way of detecting fetal DNA in maternal blood, proving that the technique isn't inventive.
-
March 10, 2025
UPC Nixes Tridonic's Infringement Case Over Boost Converter
Europe's patent court has sided with Cupower in a dispute over a circuit that improves power use in electrical devices, ruling that its technology didn't incorporate a key feature from Tridonic's patent.聽
-
March 10, 2025
Kenwood Chef Maker Loses Challenge To 'Misterchef' TM
DeLonghi, which owns kitchen appliance brand Kenwood, has failed to convince trademark officials that a rival's "Misterchef" mark would piggyback off of Kenwood's prestige, with officials finding that shoppers wouldn't mistake it for a Kenwood creation.
-
March 10, 2025
IBM Wins Software Reverse Engineering Claim Against Rival
A聽London judge ruled Monday that a tech firm breached its customer agreement with IBM by reverse engineering the computing giant's software to help develop a competing product.
-
March 10, 2025
AstraZeneca's $1B Drug Protections Too Vague, Generics Say
Generic drugmakers urged the High Court to revoke patent protections for AstraZeneca's $1 billion Type-2 diabetes treatment Forxiga at the start of invalidity proceedings on Monday as the pharmaceutical companies hope to clear the way to launch their competitor medicines.
-
March 10, 2025
Harvard, MIT Relinquish CRISPR Gene Editing Patent
The Broad Institute and a trio of U.S. universities have given up one of their jointly owned gene editing patents after a European appeals panel warned that it would likely invalidate the patent.
-
March 07, 2025
Chinese Medical Co.'s Suction Device Patent Claim Backfires
A Chinese medical device maker on Friday failed to convince a London court that a British rival infringed its patent for a suction device to remove kidney stones because the patented technology found in its rival's products was standard practice.
-
March 07, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen an Iranian oil company sued for聽$95 million, Betfred hit with a lawsuit from a property company and聽NHS England face a human rights claim brought by a man detained under the Mental Health Act for over 20 years. Here, 麻豆传媒360 looks at these and other new claims in the U.K.
-
March 07, 2025
Flower Biz Hits Back At Rival In Google Search TM Fight
A fresh flower retailer has denied infringing a rival's trademarks by using its name as a keyword for Google ads, telling a London court that it has stuck to a longstanding agreement not to do so.
-
March 07, 2025
EU Court Rules Against Forced Transfer Of Musician Rights
The National Orchestra of Belgium cannot force its musicians to transfer their intellectual property rights to their employer without consent, the European Union's top court ruled, in a move that offers stronger protections for performers in the digital and live-performance sectors.
-
March 07, 2025
EasyGroup Beats Challenge To 'EasyCasa' TM
European officials have given easyGroup the greenlight to market furniture and household goods under the "easyCasa" trademark, after ruling that a Turkish lifestyle brand had failed to show it had genuinely used the "Casa" name in Western Europe.
-
March 07, 2025
Toy Maker Drops EU Trademark Appeal Over Rubik's Cube
A toy company has ended its appeal against a decision to shun its bid for a trademark in the European Union covering a 3D picture that resembles a Rubik's Cube.
-
March 06, 2025
Don't Give Teva 'Eighth Bite' At $235M Patent Trial, GSK Says
GlaxoSmithKline has told a Delaware federal judge that Teva's request for a new trial in the drugmakers' decade-long, $235 million "skinny label" patent fight over heart failure medication is an "eighth bite at the same apple."
-
March 06, 2025
Visual Variations Argued As Key In 'Lego Exception' Designs
Courts should look at the "overall impression" that a connector makes in the context of a broader modular system in order to decide whether the design merits intellectual property protections, an adviser to the European Union's highest court said Thursday in a case that could affect how something called the "Lego exception" applies.
-
March 06, 2025
Ericsson Can't Take Lenovo License Feud To Top UK Court
A London appeals court has refused Ericsson's bid to have the U.K.'s top court consider its ongoing licensing feud with Lenovo after ruling that a "willing licensor" in the Swedish company's position would have agreed to an interim license.
-
March 06, 2025
Stoma Bag Maker Beats Rival's Patent Infringement Case
A medical device maker can continue selling a stoma bag that collects waste from people with diverted colons, after convincing a London judge that it wasn't infringing a rival's patent that reduced bulging.聽
-
March 06, 2025
Tesla Fails To Revive 5G FRAND Feud With Avanci, InterDigital
A London appeals court refused on Thursday to restart Tesla's attempt to sue Avanci and InterDigital in the U.K. over licensing rates for a 5G patent pool, drawing a boundary on its jurisdiction over such disputes.
-
March 06, 2025
Crocs Can't Block Rival's Moccasin-Like EU Shoe Design
European officials have rejected Crocs' challenge to a rival's shoe design, ruling that just because it shared features with boat shoes or stitched Moccasins didn't mean shoppers wouldn't notice it was a sportier aesthetic.
-
March 05, 2025
Enedo Loses Appeal For TM Over Similarity With Enedis
A European court has dismissed a bid from Finnish electrics manufacturer Enedo to reinstate a trademark application for "Enedo: Reshaping Electricity," with the court holding that the name clashes with a rival's branding.
-
March 05, 2025
Alibaba Denies Control Over Copycat Dr. Martens Adverts
E-commerce site Alibaba has told a London court that it played no part in creating sponsored online advertising containing trademarks owned by Dr. Martens, but claims that the iconic leather boot brand also has not genuinely used all its trademarks.
-
March 05, 2025
Gambling Biz Defends 'Undercover Joker' TM Bid At EU Court
A European Union court on Wednesday tossed an Eckes-Granini unit's latest attempt to halt a gambling company's "Undercover Joker" trademark bid, ruling that consumers would not mix up the sign with the juice giant's earlier "Joker+" mark.
-
March 05, 2025
Philip Morris Saves E-Cig Power Supply Patent At EPO
Tobacco manufacturer Philip Morris Products retained its patent for a type of power supply for electronic vapes, with European patent officials tossing a challenge from a British American Tobacco unit.
-
March 05, 2025
Snapchat Can't Get TM For Descriptive 'Snap AI' In Europe
The company behind social media platform Snapchat lost its bid for the trademark "Snap AI," after European officials were left unconvinced that the mark is more than just a description of its in-app artificial intelligence tools.
-
March 05, 2025
10x Genomics Dodges Appeal In DNA Analysis Patent Clash
A bioscience company has dropped its appeal against a ruling by the Unified Patent Court that it might have infringed 10x Genomics' patent with a version of its DNA analyzing technology.
Expert Analysis
-
Strategic Considerations In Selecting Emergency Arbitration
In recent years, all of the major arbitral institutions have introduced an emergency arbitration procedure, yet studies suggest that parties rarely avail themselves of emergency arbitration and instead turn to local courts in times of crisis. Attorneys with Kirkland & Ellis LLP explore several considerations when determining where to pursue emergency relief.
-
Strategies For Protecting Biotechnology In Brazil And China
Brazil and China have taken important steps to become significant contributors to the future success of the bioeconomy. Understanding options for quickly procuring and challenging patents in Brazil and China can be key for companies looking to expand their bioeconomy investments outside the U.S. and Europe, say attorneys with Sterne Kessler Goldstein & Fox PLLC.
-
How The FTC Has Erred On Innovation Policy Issues
Maureen Ohlhausen, the acting chairman of the Federal Trade Commission, recently delivered a sobering attack on the agency, noting that it and other antitrust agencies have 鈥渓ost sight of core antitrust principles.鈥 From such a highly competent federal official who is also a recognized legal scholar, this critique deserves our full attention, says David Teece, chairman of Berkeley Research Group LLC.
-
Dairy Vs. Plant-Based 'Milks': A Regulatory Standoff
Sales of nondairy milk alternatives are flourishing, but the dairy industry charges the U.S. Food and Drug Administration with failing to enforce its own labeling regulations regarding the definition of "milk." The longer terms like soy milk, almond milk and coconut milk remain in use, the stronger the argument for their continued use to describe these products, say attorneys with Shook Hardy & Bacon LLP.
-
UK Supreme Court Broadens Scope Of Patent Protection
The U.K. Supreme Court鈥檚 recent judgment in Actavis v. Eli Lilly sets out a revised approach to assessing patents in the U.K. and is likely to confer greater protection on patent owners, by providing that the protection afforded to a patent is not limited to the wording of the claims, say attorneys with Dechert LLP.
-
Brexit Creates Uncertainty For IP
Following Brexit, if the EU regulations directly applicable to intellectual property law are not transposed into English or Scottish law, a regulatory vacuum could be created. For patents, this could mean the first lack of substantive legal protection in over 700 years, says Roberta Young of Loza & Loza LLP.
-
Guest Feature
An Interview With Floyd Abrams
It was a privilege to spend a half-hour on the phone with the nation's foremost First Amendment lawyer. Floyd Abrams and I discussed his career, his new book and what he sees in his free-speech crystal ball. And he was a very good sport when I asked if it is constitutionally protected to yell inside a movie theater: 鈥淐itizens United is a terrible decision and should be set on fire,鈥 says Randy Maniloff of White and Williams LLP.
-
An Interview With Ex-USPTO Director Todd Dickinson: Part 2
During a recent conversation with us, Q. Todd Dickinson, former director of the U.S. Patent and Trademark Office, offered his thoughts on intellectual property legislative and judicial activity in recent years, the policies that could use improvement, and the challenges that lie ahead for patent holders, say David Haas and Scott Weingust of Stout Risius Ross LLC.
-
An Interview With Ex-USPTO Director Todd Dickinson: Part 1
David Haas and Scott Weingust of Stout Risius Ross LLC recently had a candid discussion with Q. Todd Dickinson, former director of the U.S. Patent and Trademark Office and current head of Polsinelli PC鈥檚 intellectual property public policy practice. He shared his thoughts on the evolution of IP policy since his time at the PTO and his current concerns about U.S. patent law.
-
How China Became An IP Superpower
China has repeatedly been labeled an intellectual property pirate and wholesale IP rights violator, but those labels are no longer accurate. Today, applicants who overlook China do so at their peril, says Jay Erstling, of counsel at Patterson Thuente Pedersen PA and former director of WIPO's Patent Cooperation Treaty Office.
-
Real-World IP Tools In Virtual Worlds
Nonmillennials usually approach things like virtual reality from the perspective of what we know as the 鈥渞eal鈥 world. We compare objects and interactions with how they would be if generated by Mother Nature. This is the greatest challenge for intellectual property professionals working in a virtual environment, say Elizabeth Ferrill of Finnegan Henderson Farabow Garrett & Dunner LLP and Joacim Lyd茅n of Awapatent.
-
Filing Foreign Patents: 3rd-Party Disclosure Considerations
For U.S. patent applications filed following a disclosure of the invention, the one-year grace period provides a useful safety net. However, in other territories much stricter rules apply, say Hannah Buckley and Stuart Lumsden of Marks & Clerk.
-
EU May Soon Surpass US As Patent Center
Despite some uncertainty surrounding Brexit鈥檚 impact, the changing patent regime in Europe likely will make things easier for patent holders. Indeed, the new Unified Patent Court has several features that suggest it will be an appealing alternative to U.S. patent courts, say Ashley Keller and Katharine Wolanyk of Burford Capital LLC.
-
What To Expect From NPE Activity In China
An affiliate of nonpracticing entity Wi-LAN recently filed a patent suit against Sony in Nanjing, China. NPE activities have rarely been seen in China, so this raises the concern that international NPEs are now stepping in. Chinese patent litigation practice has two factors favorable to NPEs and two factors not favorable to NPEs, says Jackie Wong, legal counsel at Xiaomi Inc.
-
US Patent Practice Drifting Toward Approach Prevalent Abroad
Post-Alice cases on technical problems and technical solutions show that a problem-solution standard similar to the one adopted in Europe, Australia, China and Japan is seeing express endorsement by U.S. courts adjudicating Section 101 challenges, say Gurneet Singh and Harold Laidlaw of Mintz Levin Cohn Ferris Glovsky and Popeo PC.